[Fentanyl]

Area of Science:

• Anesthesiology and Pharmacology

Background:

• Fentanyl is an effective opioid analgesic for acute pain.
• Its slow elimination can cause prolonged respiratory depression and sedation.
• Fat distribution impacts fentanyl's pharmacokinetic profile.

Purpose of the Study:

• To review fentanyl's pharmacokinetics and associated risks.
• To highlight patient populations at higher risk for adverse events.
• To emphasize the need for updated clinical guidelines.

Main Methods:

• Literature review of fentanyl's properties and clinical use.
• Analysis of factors influencing fentanyl elimination and side effects.
• Identification of high-risk patient profiles and scenarios.

Main Results:

• Fat tissue acts as a reservoir, prolonging fentanyl's effects.
• Ideal body weight dosing is recommended to mitigate risks.
• Overweight patients, those with lung disease, or on concurrent sedatives are high-risk.
• Delayed and sleep-related adverse events are significant concerns.

Conclusions:

• Clinical guidelines for post-fentanyl administration monitoring are necessary.
• Optimizing fentanyl dosing based on ideal body weight is crucial.
• Awareness of delayed and sleep-related side effects is vital for patient safety.